Ga-68-NGUL

N/A

Report date: 2025/11/20 13:28:17

NME

Base Information

Drug NameGa-68-NGUL

Drug Alias NameGa-68-NOTA Glu-Urea-Lys68Ga-NOTA Glu-Urea-Lys68Ga-NGUL

ClassificationRadiation-emitting products > Nuclides > Gallium > 68GaRadiation-emitting products > Radionuclide Drug ConjugatesRadiation-emitting products > Radioactive diagnostic agent +[4]

Mechanisms of ActionPositron-emission tomography enhancersTomography enhancersProstate-Specific Membrane Antigen modulators

TargetsProstate-Specific Membrane Antigen

Therapy Area/IndicationsProstatic Neoplasms, Castration-ResistantProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesCellbion Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesCellbion Co Ltd

Inactive CompaniesN/A

Active IndicationsProstatic Neoplasms, Castration-ResistantProstatic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A